Long-term phenotypic correction in factor IX knockout mice by using phiC31 integrase-mediated gene therapy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Gene Therapy

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/gt.2011.31PMID 21412285PMCID PMC6070132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics and Longevity of ϕC31 Integrase in Mouse Liver and Cultured Cells

  2010cited by this paper
• Impact of Hydrodynamic Injection and phiC31 Integrase on Tumor Latency in a Mouse Model of MYC-Induced Hepatocellular Carcinoma

  2010cited by this paper
• The secondary bleeding time; a new method for the differentiation of hemorrhagic diseases.

  2009cited by this paper
• Progress toward liver‐based gene therapy

  2009cited by this paper
• Mutational derivatives of PhiC31 integrase with increased efficiency and specificity.

  2009cited by this paper
• Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV

  2009cited by this paper
• Image-guided, lobe-specific hydrodynamic gene delivery to swine liver.

  2009cited by this paper
• Gene Therapy for Hemophilia: Clinical Trials and Technical Tribulations

  2009cited by this paper
• Gene therapy for haemophilia

  2008cited by this paper
• Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose.

  2008cited by this paper
• Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human

  2008cited by this paper
• Immune responses to AAV in clinical trials.

  2007cited by this paper
• Pig liver gene therapy by noninvasive interventionist catheterism

  2007cited by this paper
• The phiC31 integrase system for gene therapy.

  2006cited by this paper
• Integration specificity of phage phiC31 integrase in the human genome.

  2006cited by this paper
• P[acman]: A BAC Transgenic Platform for Targeted Insertion of Large DNA Fragments in D. melanogaster

  2006cited by this paper
• Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver.

  2006cited by this paper
• In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery.

  2005cited by this paper
• In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery.

  2005cited by this paper
• Human endostatin gene transfer, either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells in vivo.

  2004cited by this paper
• Creation of a mouse expressing defective human factor IX.

  2004cited by this paper
• A novel therapeutic approach combining human plasma‐derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone

  2003cited by this paper
• Site-specific genomic integration produces therapeutic Factor IX levels in mice

  2002cited by this paper
• Use of blood outgrowth endothelial cells for gene therapy for hemophilia A.

  2002cited by this paper
• Gene therapy for hemophilia

  2001cited by this paper
• A Tail Vein Bleeding Time Model and Delayed Bleeding in Hemophiliac Mice

  2001cited by this paper
• Site-Specific Genomic Integration in Mammalian Cells Mediated by Phage φC31 Integrase

  2001cited by this paper
• Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A.

  2001cited by this paper
• Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.

  2000cited by this paper
• A phage integrase directs efficient site-specific integration in human cells.

  2000cited by this paper
• The rhesus macaque as an animal model for hemophilia B gene therapy.

  1999cited by this paper
• High Levels of Foreign Gene Expression in Hepatocytes after Tail Vein Injections of Naked Plasmid DNA

  1999cited by this paper
• Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA

  1999cited by this paper
• Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

  1999cited by this paper
• Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators.

  1998cited by this paper
• Human factor IX corrects the bleeding diathesis of mice with hemophilia B.

  1998cited by this paper
• Occurrence of hemophilia in the United States

  1998cited by this paper
• In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family.

  1998cited by this paper
• A coagulation factor IX-deficient mouse model for human hemophilia B.

  1997cited by this paper
• The Molecular Genetics of Haemostasis and Its Inherited Disorders

  1994cited by this paper
• Canine hemophilia B resulting from a point mutation with unusual consequences.

  1989cited by this paper
• Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats.

  1979cited by this paper
• The Metabolic Basis of Inherited Diseases

  1972cited by this paper

• Transformative approaches in hemophilia management: from traditional therapies to prenatal stem cell treatment

  2025cites this paper
• The use of site-specific recombination and cassette exchange technologies for monoclonal antibody production in Chinese Hamster ovary cells: retrospective analysis and future directions

  2020cites this paper
• Global mapping of binding sites for phic31 integrase in transgenic maden-darby bovine kidney cells using ChIP-seq

  2019cites this paper
• Application of phiC31 integrase system in stem cells biology and technology: a review

  2018cites this paper
• Translational Advances of Hydrofection by Hydrodynamic Injection

  2018cites this paper
• Cationic microbubbles and antibiotic-free miniplasmid for sustained ultrasound-mediated transgene expression in liver.

  2017cites this paper
• Gene Therapy for Liver Disease

  2017cites this paper
• Non-Invasive Imaging Serum Amyloid A Activation through the NF-κB Signal Pathway upon Gold Nanostructure Exposure.

  2016cites this paper
• Ultrasound-targeted hepatic delivery of factor IX in hemophiliac mice

  2016cites this paper
• Gene therapy for bleeding disorders

  2016cites this paper
• Phage Integrases for Genome Editing

  2016cites this paper
• Liver‐targeted gene therapy: Approaches and challenges

  2015cites this paper
• Nonviral Genome Modification Strategies for Gene Therapy: Transposon, Integrase, and Nuclease Systems

  2015cites this paper
• Gene therapy for hemophilia.

  2015cites this paper
• Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system

  2015cites this paper
• Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage

  2014cites this paper
• Bacteriophage recombination systems and biotechnical applications

  2014cites this paper
• Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity

  2014cites this paper
• Recombinase-Mediated Reprogramming and Dystrophin Gene Addition in mdx Mouse Induced Pluripotent Stem Cells

  2014cites this paper
• Bacteria-Human Somatic Cell Lateral Gene Transfer Is Enriched in Cancer Samples

  2013cites this paper
• Establishment of Stable Reporter Expression for In Vivo Imaging of Nuclear Factor-κB Activation in Mouse Liver

  2013cites this paper
• Site-directed insertion of transgenes

  2013cites this paper
• HUH site-specific recombinases for targeted modification of the human genome.

  2013cites this paper
• PhiC31 integrase‐mediated genomic integration and stable gene expression in the mouse mammary gland after gene electrotransfer

  2013cites this paper
• Site-Specific Recombination Using PhiC31 Integrase

  2013cites this paper
• Fast identification of reliable hosts for targeted cell line development from a limited‐genome screening using combined φC31 integrase and CRE‐Lox technologies

  2013cites this paper
• Advancements in Non Viral Gene Therapy for Hemophilia

  2012cites this paper
• High levels of gene expression in the hepatocytes of adult mice, neonatal mice and tree shrews via retro-orbital sinus hydrodynamic injections of naked plasmid DNA.

  2012cites this paper
• Efficacy and Site-Specificity of Adenoviral Vector Integration Mediated by the Phage φC31 Integrase

  2012cites this paper
• Animal models of hemophilia.

  2012cites this paper
• Animal Models for Hydrodynamic Gene Delivery

  2012cites this paper
• Site‐specific recombinases: from tag‐and‐target‐ to tag‐and‐exchange‐based genomic modifications

  2011cites this paper
• Therapeutic Applications of the PhiC31 Integrase System

  2011cites this paper
• Site‐Specific Recombinase Strategy to Create Induced Pluripotent Stem Cells Efficiently with Plasmid DNA

  2011cites this paper
• [Ultrasound-mediated gene delivery].

  2011cites this paper
• The therapeutic potential of phiC31 integrase as a gene therapy system

  2011influential citation
• Targeting therapeutic vector expression and integration for gene therapy applications

  2011cites this paper